Monopar Therapeutics (MNPR) Strengthens Financial Stability with $17.7M Public Offering
Monopar Therapeutics Inc. (MNPR) is a clinical-stage biotechnology company dedicated to transforming the treatment landscape for rare diseases…
Browsing Tag